A Randomized, Double-Blind, Double-Dummy, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of Oral Once-Daily Administration of TAK-438 10 or 20 mg Compared to Lansoprazole 15 mg in the Maintenance Treatment of Subjects With Endoscopic Healing of Erosive Esophagitis
收藏DataCite Commons2025-10-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007239/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a comparative study of vonoprazan (TAK-438) (10 mg or 20 mg) in participants in whom
endoscopic healing of erosive esophagitis has been confirmed with vonoprazan or adequate
treatment with a proton pump inhibitor (PPI), to demonstrate the non-inferiority of
vonoprazan to lansoprazole in their maintenance treatment (6 months or 24 weeks) as well as
to determine the clinically recommended dose for vonoprazan for maintenance therapy in
erosive esophagitis.
提供机构：
Vivli
创建时间：
2021-06-25
